FOR
IMMEDIATE RELEASE
PANCREATIC CANCER RANKS AMONG DEADLIEST FOR
MANY REASONS, SAYS PANCAN
PanCAN President and Founder Testifies on
Lack of Progress
Being Made in Pancreatic Cancer Early Detection Methods,
Research, Treatment Programs
EL SEGUNDO, Calif. U.S.A. (May 8, 2003)
- Pancreatic Cancer Action Network (PanCAN) President and Founder
Paula Kim said there are many reasons why pancreatic cancer still
ranks among the deadliest cancers. Kim testified yesterday before
the subcommittee on Labor, Health and Human Services, Education
and Related Agencies, of the U.S. House of Representatives Committee
on Appropriations. PanCAN is the first national patient-based advocacy
organization for the pancreatic cancer community, including patients,
families, medical researchers and physicians.
In her testimony, Kim said that only 10 fully-funded researchers
exist nationwide who are 100 percent dedicated to pancreatic cancer,
and there are limited funding opportunities for researchers who
want to study the disease. “The combination of few dollars
and few researchers means there has been very little scientific
research,” said Kim.
Kim outlined opportunities for the federal government to take
action to facilitate progress in combating the disease, including
providing adequate funding and creating ways to attract early and
experienced investigators to the field of pancreatic cancer.
“Our goal is to make inroads against this disease so that
in the near future the diagnosis of pancreatic cancer will no longer
be a virtual death sentence,” said Kim.
Facts About Pancreatic Cancer
• Pancreatic Cancer is the No. 4 cancer killer in
the United States among both men and women.
• Approximately 30,700 people will be diagnosed with pancreatic
cancer this year in the United States
and 30,000 people will die.
• The 99% mortality rate for pancreatic cancer is the highest
of any cancer.
• Research spending per pancreatic cancer fatality is only
$779, the lowest of any leading cancer.
• No effective early detection methods have been developed.
There are minimal treatment options available.
Important information and guidance is available to pancreatic cancer
patients and their families through PanCAN's Patient and Liaison
Services (PALS). Call 877-272-6226 or e-mail medinfo@pancan.org.
About PanCAN
PanCAN is a 501(c)(3) nonprofit organization founded in 1999 by
surviving family members of individuals who died of pancreatic cancer.
Chartered as a grassroots organization of advocacy for pancreatic
cancer patients and their families, PanCAN currently has volunteers
and members throughout the United States and around the world. PanCAN
is the first, national public-benefit advocacy organization for
the pancreatic cancer community. The organization works to focus
national attention on the need to find a cure for pancreatic cancer,
and provides public and professional education embracing the urgent
need for more research, effective treatments, prevention programs
and early detection methods. Visit www.pancan.org
to obtain more information, e-mail info@pancan.org,
or call 1-877-272-6226.
About ASCO
ASCO is the world's leading professional society of multidisciplinary
medical professionals who treat people with cancer. ASCO's more
than 20,000 members from the U.S. and abroad set the standard for
patient care worldwide and lead the fight for more effective cancer
treatments, increased funding for clinical and translational research,
and, ultimately, cures for the many different cancers that strike
1.3 million Americans every year. ASCO publishes the semi-monthly
Journal of Clinical Oncology (JCO), the foremost, peer-reviewed
journal focusing on clinical cancer research, and produces the award-winning
website People Living With Cancer (www.plwc.org), which provides
oncologist-vetted cancer information to help patients and families
make informed healthcare decisions.
###
Media Contacts:
Aaron Kiel
Public Relations Consultant for PanCAN
Phone: 562-983-8113
Email: akiel@akprgroup.com
Company Contacts:
Julie Fleshman
Executive Director, PanCAN
Phone: 310-725-0025
Email: jfleshman@pancan.org
|